Why should progesterone be taken during menopause?

Why Progesterone is Taken in Menopause

Progesterone is added to estrogen therapy in menopausal women with an intact uterus specifically to prevent endometrial hyperplasia and cancer—this is its primary and essential indication, not for treating menopausal symptoms themselves. 1

Critical Distinction: Prevention vs. Treatment

The evidence clearly separates two contexts:

1. Endometrial Protection (Primary Indication)

For postmenopausal women taking estrogen who still have a uterus, progesterone is mandatory, not optional 1:

• Unopposed estrogen increases endometrial cancer risk in women with an intact uterus 2
• Adding a progestogen reduces this cancer risk to acceptable levels
• Standard dosing: 200 mg oral micronized progesterone at bedtime for 12 continuous days per 28-day cycle 1
• This is FDA-approved specifically for "prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women receiving conjugated estrogens" 1

Critical caveat: Women who have had a hysterectomy do not need progesterone when taking estrogen, as there is no endometrium to protect 2.

2. Symptom Management (Secondary, Off-Label Use)

Progesterone monotherapy (without estrogen) can treat vasomotor symptoms in women with contraindications to estrogen 3, 4, 5:

• Efficacy: 300 mg oral micronized progesterone showed 55-59% reduction in hot flashes versus 23.5% with placebo 4
• Additional benefits: Improves sleep quality and does not cause depression 4
• Use case: Women with history of venous thromboembolism, coronary artery disease, certain gynecologic cancers, or other estrogen contraindications 5

However, the USPSTF explicitly states their recommendations do not apply to symptom management—only to chronic disease prevention 2.

Important Safety Context

The USPSTF recommends against combined estrogen-progestin therapy for chronic disease prevention (Grade D recommendation) 2:

• Increases risk of stroke, breast cancer, dementia (age ≥65), blood clots, and gallbladder disease
• Does not prevent heart disease and may increase cardiac events
• These harms outweigh benefits like fracture reduction

This does not mean progesterone should be avoided—it means:

• Use hormone therapy only for symptom management, not disease prevention
• In women taking estrogen for symptoms who have a uterus, progesterone remains necessary for endometrial protection
• Use the lowest effective dose for the shortest duration needed

Clinical Algorithm

For women considering menopause hormone therapy:

1. Does she have a uterus?

   • Yes → If taking estrogen, must add progesterone (200 mg/day for 12-14 days/month) 1, 6
   • No → Progesterone not needed with estrogen 2

2. Does she have contraindications to estrogen?

   • Yes → Consider progesterone monotherapy (300 mg/day) for vasomotor symptoms 4, 5
   • No → Standard estrogen therapy (with progesterone if uterus present)

3. Contraindications to progesterone itself:

   • Unexplained vaginal bleeding
   • Personal history of breast cancer
   • Peanut allergy (for capsule formulations) 1
   • Pregnancy

Key Pitfalls to Avoid

• Never give estrogen alone to women with a uterus—this substantially increases endometrial cancer risk 2
• Do not confuse chronic disease prevention (not recommended) with symptom management (appropriate indication) 2
• Progesterone causes drowsiness/dizziness—must be taken at bedtime 1
• Side effects (headaches, vaginal bleeding) led to discontinuation in 6-21% of patients in trials 3
• Transdermal progesterone does not provide adequate endometrial protection 6